Pretreatment of leukemic cells with low-dose decitabine markedly enhances the cytotoxicity of gemtuzumab ozogamicin

Detalles Bibliográficos
Autores principales: Kurimoto, M, Matsuoka, H, Hanaoka, N, Uneda, S, Murayama, T, Sonoki, T, Nakakuma, H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3542629/
https://www.ncbi.nlm.nih.gov/pubmed/22814292
http://dx.doi.org/10.1038/leu.2012.178

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3542629/
https://www.ncbi.nlm.nih.gov/pubmed/22814292
http://dx.doi.org/10.1038/leu.2012.178

Ejemplares similares